Skip to main content
logo
Valion Bio, Inc. (VBIO)
NASDAQ: VBIO · Real-Time Price · USD
2.260
+0.070 (3.20%)
Oct 8, 2026, 2:00 PM EDT - Market open

Valion Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-18.75-8.88-5.66-8.24-10.1-8.49
Depreciation & Amortization
0.790.010.350.180.170.02
Other Amortization
1.030.1---1.75
Stock-Based Compensation
0.630.560.230.270.40.06
Provision & Write-off of Bad Debts
-----0.07
Other Operating Activities
1.111.141.190.03-1.39
Change in Accounts Receivable
----0.070-0.07
Change in Inventory
-0.75--0.08-0.43-0.18
Change in Accounts Payable
0.410.14-0.59-0.610.530.42
Change in Other Net Operating Assets
1.020.31-0.61-0.150.5-0.58
Operating Cash Flow
-14.58-7-5.73-8.51-8.92-5.61
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.1-0.04--0.12-0.01-
Sale (Purchase) of Intangibles
--0.54----
Other Investing Activities
-0.12-0.12----
Investing Cash Flow
-0.22-0.71--0.12-0.01-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-----0.1
Long-Term Debt Issued
-----2.51
Total Debt Issued
-----2.61
Long-Term Debt Repaid
------0.02
Net Debt Issued (Repaid)
-----2.59
Issuance of Common Stock
0.52.454.388.510.0614.95
Other Financing Activities
-0.27-0.31-0.05--0.58-
Financing Cash Flow
16.0918.354.338.51-0.5317.54

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
1.2910.64-1.39-0.12-9.4611.93

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-14.67-7.04-5.73-8.63-8.93-5.61
Free Cash Flow Growth
------
Free Cash Flow Margin
----733.76%-485.33%-446.46%
Free Cash Flow Per Share
-160.40-152.25-498.04---
Levered Free Cash Flow
-8.06-4.29-2.53-4.79-5.57-3.88
Unlevered Free Cash Flow
-8.17-4.3-2.53-4.79-5.57-4.48

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
0.680.45-1.19-0.750.61-0.4
SEC Filings: 10-K · 10-Q